Chemical Warfare, Chemical Terrorism, and Traumatic Stress Responses: An Assessment of Psychological Impact

Chemical Warfare Agents: Chemistry, Pharmacology, Toxicology, and Therapeutics

Volumn , Issue , 2007, Pages 627-652

  Romano, James A ^a   Lumley, Lucille A ^b   King, James M ^c   Saviolakis, George A ^d  

^a SAIC FREDERICK INC   (United States)

^b US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

^c U S ARMY RESEARCH LABORATORY   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84899327312     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420046625-28     Document Type: Chapter

References (177)

1. Abenhaim, L., W. Dab and L.R. Salmi. 1992. Study of civilian victims of terrorist attacks (France 1982-1987). J Clin Epidemiol 45(2): 103-9.
2. APA. 1994. DSM IV: Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.
3. APA Online. 2006. Injury Severity Linked to PTSD. www.psycport.com (accessed October 4, 2006).
4. Araki, T., K. Kasai, H. Yamasue, et al. 2005. Association between lower P300 amplitude and smaller anterior cingulate cortex volume in patients with posttraumatic stress disorder: a study of victims of Tokyo subway sarin attack. Neuroimage 25(1): 43-50.
5. Balali-Mood, M. 1996. Delayed toxic effects of sulfur mustard in 1428 patients. In Proceedings of the Chemical Biological Medical Treatment Symposium: An Exploration of Present Capabilities and Future Requirements, 125-133. Spiez, Switzerland.
6. Balali-Mood, M. and M. Hefazi. 2006. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 99(4): 273-82.
7. Balali-Mood, M. and A. Navaeian. 1986. Clinical and paraclinical findings in 233 patients with sulfur mustard poisoning. In Proceedings of the Second World Congress on New Compounds in Biological and Chemical Warfare: Toxicological Evaluation, 464-473, B. Heyndrickx, ed. Ghent, Ghent University Press.
8. Becker, S.M. 2001. Meeting the threat of weapons of mass destruction terrorism: toward a broader conception of consequence management. Mil Med 166(12 Suppl): 13-6.
9. Bohus, B., J. Koolhaas, C. Nyakas and A. Steffens. 1987. Physiology of Stress: A Behavioral View. CEC programme of coordination research on animal welfare, Oosterbeek, Netherlands, 42: 57-70. M. Nijhoff for the Commission of the European communities.
10. Bohus, B., J.M. Koolhaas, A.J. De Ruiter and C.J. Heijnen. 1991. Stress and differential alterations in immune system functions: conclusions from social stress studies in animals. Neth J Med 39(3-4): 306-15.
11. Bowler, R.M., D. Mergler, G. Huel and J.E. Cone. 1994a. Psychological, psychosocial, and psychophysiological sequelae in a community affected by a railroad chemical disaster. J Trauma Stress 7(4): 601-24.
12. Bowler, R.M., D. Mergler, G. Huel and J.E. Cone. 1994b. Aftermath of a chemical spill: psychological and physiological sequelae. Neurotoxicology 15(3): 723-9.
13. Bowler, R.M., C. Hartney and L.H. Ngo. 1998. Amnestic disturbance and posttraumatic stress disorder in the aftermath of a chemical release. Arch Clin Neuropsychol 13(5): 455-71.
14. Bremner, J.D. 2006. The relationship between cognitive and brain changes in posttraumatic stress disorder. Ann N Y Acad Sci 1071: 80-6.
15. Brezenoff, H.E., J. McGee and N. Hymowitz. 1985. Effect of soman on schedule-controlled behavior and brain acetylcholinesterase in rats. Life Sci 37(25): 2421-30.
16. Bronson, F.H. 1979. The reproductive ecology of the house mouse. Q Rev Biol 54(3): 265-99.
17. Brown, M.A. and K.A. Brix. 1998. Review of health consequences from high-, intermediate- and low-level exposure to organophosphorus nerve agents. J Appl Toxicol 18(6): 393-408.
18. Bryant, R.A. 2006. Longitudinal psychophysiological studies of heart rate: mediating effects and implications for treatment. Ann N Y Acad Sci 1071: 19-26.
19. Buccafusco, J.J., D.L. Heithold and S.H. Chon. 1990. Long-term behavioral and learning abnormalities produced by the irreversible cholinesterase inhibitor soman: effect of a standard pretreatment regimen and clonidine. Toxicol Lett 52(3): 319-29.
20. Burchfiel, J.L., F.H. Duffy and M. Van Sim. 1976. Persistent effects of sarin and dieldrin upon the primate electroencephalogram. Toxicol Appl Pharmacol 35(2): 365-79.
21. Bushnell, P.J., S.S. Padilla, T. Ward, C.N. Pope and V.B. Olszyk. 1991. Behavioral and neurochemical changes in rats dosed repeatedly with diisopropylfluorophosphate. J Pharmacol Exp Ther 256(2): 741-50.
22. Cahill, L., C.A. Pham and B. Setlow. 2000. Impaired memory consolidation in rats produced with betaadrenergic blockade. Neurobiol Learn Mem 74(3): 259-66.
23. Carlier, I.V., R.D. Lamberts and B.P. Gersons. 1997. Risk factors for posttraumatic stress symptomatology in police officers: a prospective analysis. J Nerv Ment Dis 185(8): 498-506.
24. Carter, B.J. and M. Cammermeyer. 1985. Biopsychological responses of medical unit personnel wearing chemical defense ensemble in a simulated chemical warfare environment. Mil Med 150(5): 239-49.
25. Carus, W.S. 1988. Chemical weapons in the Middle East. In The Washington Institute for Near East Policy. Research Memorandum 9.
26. Chang, W.E., J.M. Petras, H. Smith, et al. 2007. Low level VX increases hippocampal neurotrophin expression independent of brain pathology in mouse hippocampus. Abstracts, Society of Toxicology, 46.
27. Cohen, H., M.A. Matar, G. Richter-Levin and J. Zohar. 2006. The contribution of an animal model toward uncovering biological risk factors for PTSD. Ann N Y Acad Sci 1071: 335-50.
28. Conn, C.A., K. Dokladny, M.G. Menache, et al. 2002. Effects of sarin on temperature and activity of rats as a model for gulf war syndrome neuroregulatory functions. Toxicol Appl Pharmacol 184(2): 77-81.
29. Davis, L.L., E.C. Frazier, R.B. Williford and J.M. Newell. 2006. Long-term pharmacotherapy for posttraumatic stress disorder. CNS Drugs 20(6): 465-76.
30. de Quervain, D.J. 2006. Glucocorticoid-induced inhibition of memory retrieval: implications for post-traumatic stress disorder. Ann N Y Acad Sci 1071: 216-20.
31. Delahanty, D.L. and N.R. Nugent. 2006. Predicting PTSD prospectively based on prior trauma history and immediate biological responses. Ann N Y Acad Sci 1071: 27-40.
32. Department of Defense. 2006. Chemical and Biological Defense Program Annual Report to Congress. http:// www.acq.osd.mil/cp/nbc06/cbdpreporttocongress2006.pdf.
33. Diamond, D.S., L.H. Pastor and R.G. McIntosh. 2004. Medical management of terrorism-related behavioral syndromes. Psychiatr Ann 34(9): 689-700.
34. Engel, C.C., Jr. 2004. Post-war syndromes: illustrating the impact of the social psyche on notions of risk, responsibility, reason, and remedy. J Am Acad Psychoanal Dyn Psychiatry 32(2): 321-34; discussion 335-43.
35. Fairley, M., P. Langeluddecke and C. Tennant. 1986. Psychological and physical morbidity in the aftermath of a cyclone. Psychol Med 16(3): 671-6.
36. Friedman, M. 1998. [Clinical aspects of anticholinergic agents]. Rev Mal Respir 15(2 Suppl): S51-4.
37. Friedman, M.J. 2006. Posttraumatic stress disorder among military returnees from Afghanistan and Iraq. Am J Psychiatry 163(4): 586-93.
38. Galea, S., J. Ahern, H. Resnick, et al. 2002. Psychological sequelae of the September 11 terrorist attacks in New York City. N Engl J Med 346(13): 982-7.
39. Galea, S., D. Vlahov, H. Resnick, et al. 2003. Trends of probable post-traumatic stress disorder in New York City after the September 11 terrorist attacks. Am J Epidemiol 158(6): 514-24.
40. Geller, I., R.J. Hartmann, Jr. and E.M. Gause. 1985. Effects of subchronic administration of soman on acquisition of avoidance-escape behavior by laboratory rats. Pharmacol Biochem Behav 23(2): 225-30.
41. Genovese, R.F., B.J. Benton, S.J. Shippee, E.M. Jakubowski and J.C. Bonnell. 2006. Effects of low-level inhalation exposure to cyclosarin on learned behaviors in Sprague-Dawley rats. J Toxicol Environ Health A 69(24): 2167-80.
42. Genovese, R.F., J.L. Oubre, E.M. Jakubowski, et al. 2007. Evaluation of cognitive and biochemical effects of low-level exposure to sarin in rhesus and African green monkeys. Toxicology 231(1): 11-20.
43. Geracioti, T.D., Jr., L.L. Carpenter, M.J. Owens, et al. 2006. Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression. Am J Psychiatry 163(4): 637-43.
44. Goldberg, D.P., R. Gater, N. Sartorius, et al. 1997. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med 27(1): 191-7.
45. Grauer, E. and J. Kapon. 2004. Stress exposure and sarin poisoning: interaction of long-term effects. Israel J Psychiatry 41(1): (abstract).
46. Harris, L.W., J.H. McDonough, Jr., D.L. Stitcher and W.J. Lennox. 1984. Protection against both lethal and behavioral effects of soman. Drug Chem Toxicol 7(6): 605-24.
47. Hashemian, F., K. Khoshnood, M.M. Desai, et al. 2006. Anxiety, depression, and posttraumatic stress in Iranian survivors of chemical warfare. JAMA 296(5): 560-6.
48. Headquarters. (1966). U.S. Department of the Army; Employment of Chemical Agents, Field Manual 3-10, Washington, DC.
49. Hebert, M., A. Evenson, L. Lumley and J. Meyerhoff. 1998. Effect of acute social defeat on activity in the forced swim test: parametric studies in DBA/2 mice using a novel measurement device. Aggress Behav 24: 257-69.
50. Henderson, R.F., E.B. Barr, W.B. Blackwell, et al. 2002. Response of rats to low levels of sarin. Toxicol Appl Pharmacol 184(2): 67-76.
51. Henley, F. 1956. Mass intoxication due to explosion of shell containing dichloroethyl sulfide dating back to World War I. Annales de medicine legales 36: 195-204.
52. Hoge, C.W. and C.A. Castro. 2006. Post-traumatic stress disorder in UK and US forces deployed to Iraq. Lancet 368(9538): 837; author reply 837.
53. Hoge, C.W., A. Terhakopian, C.A. Castro, S.C. Messer and C.C. Engel. 2007. Association of posttraumatic stress disorder with somatic symptoms, health care visits, and absenteeism among Iraq war veterans. Am J Psychiatry 164(1): 150-3.
54. Howorth, P. 2000. The treatment of shell shock: cognitive therapy before its time. Psychiatr Bull 24: 225-7.
55. Hulet, S.W., J.H. McDonough and T.M. Shih. 2002. The dose-response effects of repeated subacute sarin exposure on guinea pigs. Pharmacol Biochem Behav 72(4): 835-45.
56. Hulet, S.W., D.R. Sommerville, R.B. Crosier, et al. 2006. Comparison of low-level sarin and cyclosarin vapor exposure on pupil size of the gottingen minipig: effects of exposure concentration and duration. Inhal Toxicol 18(2): 143-53.
57. Hurst, C.G., J. Newmark and J.A. Romano. 2005. Chemical bioterrorism. In Harrison’s Textbook of Internal Medicine, A. Fauci, D. Kasper, D. Longo, et al., eds. New York, NY: McGraw-Hill Companies, Inc.
58. Iyriboz, Y. 2004. A recent exposure to mustard gas in the United States: clinical findings of a cohort (n/247) 6 years after exposure. MedGenMed 6(4): 4.
59. Jehel, L., C. Duchet, S. Paterniti, S.M. Consoli and J.D. Guelfi. 2001. [Prospective study of post-traumatic stress in victims of terrorist attacks]. Encephale 27(5): 393-400.
60. Jung, B.J. and T.-M. Shih. 2006. The effects of repeated low-dose nerve agent exposure on extracellular neurotransmitter levels and electroencephalography. In Low Level Chemical Warfare Agent Toxicology Research Program FY05 Report and Analysis. AFRL/HEPC AFRL-HE-WP-TR-2006-0073.
61. Kales, S.N. and D.C. Christiani. 2004. Acute chemical emergencies. N Engl J Med 350(8): 800-8.
62. Kalra, R., S.P. Singh, S. Razani-Boroujerdi, et al. 2002. Subclinical doses of the nerve gas sarin impair T cell responses through the autonomic nervous system. Toxicol Appl Pharmacol 184(2): 82-7.
63. Karczmar, A.G. 1984. Acute and long lasting central actions of organophosphorus agents. Fundam Appl Toxicol 4(2 Pt 2): S1-17.
64. Kassa, J., M. Koupilova and J. Vachek. 2001a. The influence of low-level sarin inhalation exposure on spatial memory in rats. Pharmacol Biochem Behav 70(1): 175-9.
65. Kassa, J., M. Pecka, M. Tichy, et al. 2001b. Toxic effects of sarin in rats at three months following single or repeated low-level inhalation exposure. Pharmacol Toxicol 88(4): 209-12.
66. Kassa, J., G. Krejcova, F. Skopec, et al. 2004. The influence of sarin on various physiological functions in rats following single or repeated low-level inhalation exposure. Inhal Toxicol 16(8): 517-30.
67. Keane, T.M., A.D. Marshall and C.T. Taft. 2006. Posttraumatic stress disorder: etiology, epidemiology, and treatment outcome. Annu Rev Clin Psychol 2: 161-197.
68. Kessler, R.C., A. Sonnega, E. Bromet, M. Hughes and C.B. Nelson. 1995. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 52(12): 1048-60.
69. King, J.M. and A.J. Frelin. 1984. Impact of the chemical protective ensemble on the performance of basic medical tasks. Mil Med 149(9): 496-501.
70. Krueger, G.P. and L.E. Banderet. 1997. Effects of chemical protective clothing on military performance: a review of the issues. Mil Psychol 9: 255-86.
71. Kulka, R.A., W.E. Schlenger, J.A. Fairbank, et al. 1990. Trauma and the Vietnam War generation: Report of Findings from the National Vietnam Veterans Readjustment Study. New York, NY: Brunner/Mazel.
72. Langston, J. L., A.L. Adkins, A.V. Moran, G.A. Rockwood and M.S. Deford. 2005. Effects of sarin on the operant behavior of guinea pigs. Neurotoxicol Teratol 27(6): 841-53.
73. Leopold, R.L. and H. Dillon. 1963. Psycho-anatomy of a disaster: a long term study of post-traumatic neuroses in survivors of a marine explosion. Am J Psychiatry 119: 913-21.
74. Liu, S., L.E. Quenemoen, J. Malilay, et al. 1996. Assessment of a severe-weather warning system and disaster preparedness, Calhoun County, Alabama, 1994. Am J Public Health 86(1): 87-9.
75. Lohs, K. 1975. Delayed Toxic Effects of Chemical Warfare Agents (SIPRI Monograph). Stockholm, Sweden: Almqvist and Wilksell.
76. Lumley, L.A., M.L. Sipos, R.C. Charles, R.F. Charles and J.L. Meyerhoff. 1999. Social stress effects on territorial marking and ultrasonic vocalizations in mice. Physiol Behav 67(5): 769-75.
77. Lumley, L.A., R.F. Charles, R.C. Charles, et al. 2000. Effects of social defeat and of diazepam on behavior in a resident-intruder test in male DBA/2 mice. Pharmacol Biochem Behav 67(3): 433-47.
78. Lumley, L.A., C.A. Saviolakis, C.L. Robinson and J.L. Meyerhoff. 2001. Repeated prolonged social stress with food and water deprivation induces spatial memory impairment in mice. Society for neuroscience conference, San Francisco, CA, Prog. No. 532, 7.
79. Lumley, L.A., C.L. Robison, M. Dawood, et al. 2003. Persistent avoidance of olfactory cues associated with a prior social stress experience. XXXIII Annual Congress of the International Society of Psychoneuroendocrinology, Pisa, Italy.
80. Lumley, L.A., C.L. Robison, I.Y. Nwaneri, et al. 2005. Behavioral and physiological effects of the nerve agent VX in rats: model for assessment of neuroprotective drugs. Society for Neuroscience conference, Washington, DC, Prog. No. 337.14.
81. Lumley, L.A., C.L. Robison, A.R. Kohli, et al. 2006. Reduced body temperature and impaired motor coordination in rats exposed to sub-lethal doses of VX. In Low Level Chemical Warfare Agent Toxicology Research Program FY05 Report and Analysis. AFRL/HEPC AFRL-HE-WP-TR-2006-0073.
82. Marlowe, D. 2001. Psychological and Psychosocial Consequences of Combat and Deployment with Special Emphasis on the Gulf War in Rand, Santa Monica, CA National Defense Research Institute.
83. Marmar, C.R., S.E. McCaslin, T.J. Metzler, et al. 2006. Predictors of posttraumatic stress in police and other first responders. Ann N Y Acad Sci 1071: 1-18.
84. McDonald, B., L. Costa and S. Murphy. 1988. Spatial memory impairment and central muscarinic receptor loss following prolonged treatment with organophosphates. Toxicol Lett 40(1): 42-56.
85. McDonough, J.H., Jr. and T.M. Shih. 1997. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci Biobehav Rev 21(5): 559-79.
86. McDonough, J.H., Jr., L.W. Dochterman, C.D. Smith and T.M. Shih. 1995. Protection against nerve agentinduced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology 16(1): 123-32.
87. McDonough, J.H., Jr., T.R. Clark, T.W. Slone, Jr., et al. 1998. Neural lesions in the rat and their relationship to EEG delta activity following seizures induced by the nerve agent soman. Neurotoxicology 19(3): 381-91.
88. McEwen, B.S. 2004. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann N Y Acad Sci 1032: 1-7.
89. McGaugh, J.L. 1989. Involvement of hormonal and neuromodulatory systems in the regulation of memory storage. Annu Rev Neurosci 12: 255-87.
90. McGaugh, J.L. and I. Izquierdo. 2000. The contribution of pharmacology to research on the mechanisms of memory formation. Trends Pharmacol Sci 21(6): 208-10.
91. McNally, R.J. 2003. Progress and controversy in the study of posttraumatic stress disorder. Annu Rev Psychol 54: 229-52.
92. Meaney, M.J. 2001. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci 24: 1161-92.
93. Medical History. 1959. The 3rd division at Chateau Thierry July 1918. In US Army Chemical Corps Historical Studies: Gas Warfare in World War I. US Army Chemical Corps Historical Office 91, Study 14.
94. Meyerhoff, J.L., L.A. Lumley, C.L. Robison, et al. 2005. Chronic social stress in mice is associated with increased dendritic spine density in the amygdala. Society for Neuroscience conference, Washington, DC, Prog. No. 872.5.
95. Moreau, C. and S. Zisook. 2002. Rationale for a posttraumatic stress spectrum disorder. Psychiatr Clin North Am 25(4): 775-90.
96. Moreau, C. and S. Zisook. 2003. Rationale for a posttraumatic stress spectrum disorder. Focus 1: 265-72.
97. Morgan, C.A. and S.M. Southwick. 2000. Biological alterations in posttraumatic stress disorder: implications for research and the U.S. military. In Pennington Center Nutrition Series Volume 10: Countermeasures for Battlefield Stressors, 9-25, K. Friedl, H. Lieberman, D.H. Ryan, et al., eds. Baton Rouge, LA, Louisiana State University Press.
98. Myhrer, T., J.M. Andersen, N.H. Nguyen and P. Aas. 2005. Soman-induced convulsions in rats terminated with pharmacological agents after 45 min: neuropathology and cognitive performance. Neurotoxicology 26 (1): 39-48.
99. Nakajima, T., S. Ohta, H. Morita, et al. 1998. Epidemiological study of sarin poisoning in Matsumoto City, Japan. J Epidemiol 8(1): 33-41.
100. Nemeroff, C.B., J.D. Bremner, E.B. Foa, et al. 2006. Posttraumatic stress disorder: a state-of-the-science review. J Psychiatr Res 40(1): 1-21.
101. Newmark, J. 2004. The birth of nerve agent warfare: lessons from Syed Abbas Foroutan. Neurology 62(9): 1590-6.
102. Nieminen, S.A., A. Lecklin, O. Heikkinen and P. Ylitalo. 1990. Acute behavioral effects of the organophosphates sarin and soman in rats. Pharmacol Toxicol 67(1): 36-40.
103. North, C.S., S.J. Nixon, S. Shariat, et al. 1999. Psychiatric disorders among survivors of the Oklahoma City bombing. JAMA 282(8): 755-62.
104. North, C.S., L. Tivis, J.C. McMillen, et al. 2002a. Coping, functioning, and adjustment of rescue workers after the Oklahoma City bombing. J Trauma Stress 15(3): 171-5.
105. North, C.S., L. Tivis, J.C. McMillen, et al. 2002b. Psychiatric disorders in rescue workers after the Oklahoma City bombing. Am J Psychiatry 159(5): 857-9.
106. Oordt, M.S. 2001. Managing severe gas mask anxiety with a cognitive-behavioral approach: an illustrated case study and treatment protocol. Mil Psychol 13(3): 165-76.
107. Pavlisa, G., J. Papa, L. Pavic and G. Pavlisa. 2006. Bilateral MR volumetry of the amygdala in chronic PTSD patients. Coll Antropol 30(3): 565-8.
108. Perry, S., J. Difede, G. Musngi, A.J. Frances and L. Jacobsberg. 1992. Predictors of posttraumatic stress disorder after burn injury. Am J Psychiatry 149(7): 931-5.
109. Petras, J.M., L.A. Lumley, C. Whalley, et al. 2006. The effects of sublethal VX exposure on guinea pig physiology and behavior. In Low Level Chemical Warfare Agent Toxicology Research Program FY05 Report and Analysis. AFRL/HEPC AFRL-HE-WP-TR-2006-0073.
110. Pine, D.S., J. Costello and A. Masten. 2005. Trauma, proximity, and developmental psychopathology: the effects of war and terrorism on children. Neuropsychopharmacology 30(10): 1781-92.
111. Pitman, R.K. 1989. Post-traumatic stress disorder, hormones, and memory. Biol Psychiatry 26(3): 221-3.
112. Pitman, R.K. and S.P. Orr. 1990. Twenty-four hour urinary cortisol and catecholamine excretion in combatrelated posttraumatic stress disorder. Biol Psychiatry 27(2): 245-7.
113. Pitman, R.K., K.M. Sanders, R.M. Zusman, et al. 2002. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry 51(2): 189-92.
114. Pitman, R.K., M.W. Gilbertson, T.V. Gurvits, et al. 2006. Clarifying the origin of biological abnormalities in PTSD through the study of identical twins discordant for combat exposure. Ann N Y Acad Sci 1071: 242-54.
115. Pizarro, J.M., W.E. Chang, L.A. Lumley, et al. 2005. Analysis of hippocampal subregional changes in neurotrophin gene expression following acute social defeat stress using laser-capture microdissection and microarrays. Society for Neuroscience conference, Washington, DC, Prog. No. 59.11.
116. Prendergast, M., A. Terry and J. Buccafusco. 1997. Chronic, low-level exposure to diisopropylfluorophosphate causes protracted impairment of spatial navigation learning. Psychopharmacology 129(2): 183-91.
117. Prendergast, M., A.J. Terry and J. Buccafusco. 1998. Effects of chronic, low-level organophosphate exposure on delayed recall, discrimination, and spatial learning in monkeys and rats. Neurotoxicol Teratol 20(2): 115-22.
118. Raskin, M.A., E.R. Peskind, E.D. Kanter, et al. 2003. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry 160: 371-73.
119. Rasmusson, A.M., R.L. Hauger, C.A. Morgan, et al. 2000. Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Biol Psychiatry 47(6): 526-39.
120. Riddle, J.R., M. Brown, T. Smith, et al. 2003. Chemical warfare and the Gulf War: a review of the impact on Gulf veterans’ health. Mil Med 168(8): 606-13.
121. Ritchie, E.C. 1992. Treatment of gas mask phobia. Mil Med 157(2): 104-6.
122. Roberson, M.R., R. Chung, M.L. Clark, et al. 2006. The effects of sublethal VX exposure on guinea pig physiology and behavior. In Low Level Chemical Warfare Agent Toxicology Research Program FY05 Report and Analysis. AFRL/HEPC AFRL-HE-WP-TR-2006-0073.
123. Robison, C.L., J.L. Meyerhoff, G.A. Saviolakis, et al. 2004. A CRH1 antagonist into the amygdala of mice prevents defeat-induced defensive behavior. Ann N Y Acad Sci 1032: 324-7.
124. Robison, C.L., J.L. Meyerhoff, G.A. Saviolakis, K.C. Rice and L.A. Lumley. 2005. Administration of the CRH1 antagonist antalarmin reduces defeat-induced fear responses in mice. Society for Neuroscience conference, Washington, DC, Prog. No. 57.5.
125. Romano, J.A., Jr. and J.M. King. 2001a. Psychological casualties resulting from chemical and biological weapons. Mil Med 166(12 Suppl): 21-2.
126. Romano, J.A., Jr. and J.M. King. 2001b. Psychological factors in chemical warfare and terrorism. In Chemical Warfare Agents: Toxicity at Low Levels. S.M. Somani and J.A.J. Romano, eds. 393-408. Boca Raton, FL: CRC Press.
127. Romano, J.A., Jr. and J.M. King. 2002. Chemical warfare and chemical terrorism: psychological and performance outcomes. Mil Psychol 14(2): 85-92.
128. Romano, J.A. and T.M. Shih. 1983. Cholinergic mechanisms of analgesia produced by physostigmine, morphine and cold water swimming. Neuropharmacology 22(7): 827-33.
129. Roy, M.J., D.L. Sticha, P.L. Kraus and D.E. Olsen. 2006. Simulation and virtual reality in medical education and therapy: a protocol. Cyberpsychol Behav 9(2): 245-7.
130. Rubonis, A.V. and Bickman, 1991. Psychological impairment in the wake of disaster: the disasterpsychopathology relationship. Psychol Bull 109(3): 384-399.
131. Rush, A.J., D.E. Giles, M.A. Schlesser, et al. 1996. The dexamethasone suppression test in patients with mood disorders. J Clin Psychiatry 57(10): 470-84.
132. Russell, R.W., R.A. Booth, S.D. Lauretz, C.A. Smith and D.J. Jenden. 1986. Behavioral, neurochemical and physiological effects of repeated exposures to subsymptomatic levels of the anticholinesterase, soman. Neurobehav Toxicol Teratol 8(6): 675-85.
133. Russo-Neustadt, A. 2003. Brain-derived neurotrophic factor, behavior, and new directions for the treatment of mental disorders. Semin Clin Neuropsychiatry 8(2): 109-18.
134. Schell, T.L., G.N. Marshall and L.H. Jaycox. 2004. All symptoms are not created equal: the prominent role of hyperarousal in the natural course of posttraumatic psychological distress. J Abnorm Psychol 113(2): 189-97.
135. Schelling, G., B. Roozendaal, T. Krauseneck, et al. 2006. Efficacy of hydrocortisone in preventing posttraumatic stress disorder following critical illness and major surgery. Ann N Y Acad Sci 1071: 46-53.
136. Schnurr, P.P., M.J. Friedman and B.L. Green. 1996. Post-traumatic stress disorder among World War II mustard gas test participants. Mil Med 161(3): 131-6.
137. Schuster, M.A., B.D. Stein, L. Jaycox, et al. 2001. A national survey of stress reactions after the September 11, 2001, terrorist attacks. N Engl J Med 345(20): 1507-12.
138. Sekijima, Y., H. Morita, M. Shindo, H. Okudera and T. Shibata. 1995. [A case of severe sarin poisoning in the sarin attack in Matsumoto-one-year follow-up of clinical findings, and laboratory data]. Rinsho Shinkeigaku 35(11): 1241-5.
139. Shalev, A.Y., S. Freedman, T. Peri, et al. 1998. Prospective study of posttraumatic stress disorder and depression following trauma. Am J Psychiatry 155(5): 630-7.
140. Shalev, A.Y. and S. Freedman. 2005. PTSD following terrorist attacks: a prospective evaluation. Am J Psychiatry 162(6): 1188-91.
141. Shalev, A.Y., R. Tuval, S. Frenkiel-Fishman, H. Hadar and S. Eth. 2006. Psychological responses to continuous terror: a study of two communities in Israel. Am J Psychiatry 163(4): 667-73.
142. Sidell, F., J. Urbanetti, W.J. Smith and C.G. Hurst. 1997. Vesicants. In Medical Aspects of Chemical and Biological Warfare, 197-228, F. Sidell, E. Takafuji and D. Franz, eds. Washington, DC: Borden Institute, Walter Reed Army Medical Center.
143. Siegfried, B., H. Frischknecht and P.G. Waser. 1984. Defeat, learned submissiveness, and analgesia in mice: effect of genotype. Behav Neural Biol 42: 91-97.
144. Siegfried, B., H. Frischknecht and R. De Souza. 1990. An ethological model for the study of activation and interaction of pain, memory and defensive systems in the attacked mouse. Role of endogenous opioids. Neurosci Biobehav Rev 14: 481-90.
145. Silove, D. and R. Bryant. 2006. Rapid assessments of mental health needs after disasters. JAMA 296(5): 576-8.
146. Singh, V. 1992. Sociopsychological effects of chemical warfare agents. In Chemical Warfare Agents, 1-12, S.M. Somani, ed. San Diego, SA, Academic Press.
147. Sipos, M.L., A.V. Moran, D. Kahler, H.N. Lukefahr and S.M. DeFord. 2005. Development of a behavioral assessment model in guinea pigs to study the effects of low dose chronic exposure to chemical warfare nerve agents. In Low Level Chemical Warfare Agent Toxicology Research Program FY04 Report and Analysis. AFRL/HEPC AFRL-HE-WP-TR-2005-0054.
148. Smith, C.G., P.E. Veenhuis and J.N. MacCormack. 2000. Bioterrorism. A new threat with psychological and social sequelae. N C Med J 61(3): 150-63.
149. Smithson, A. and L.A. Levy. 2000. Ataxia: the chemical and biological terrorism threat and the US response. In Stimson Center Report No. 35. Washington, DC: Henry L. Stimson Center.
150. Solomon, Z. and M. Mikulincer. 2006. Trajectories of PTSD: a 20-year longitudinal study. Am J Psychiatry 163(4): 659-66.
151. Somani, S.M. and K. Husain. 2001. Low-level nerve agent toxicity under normal and stressful conditions. In Chemical Warfare Agents: Toxicity at Low Levels, 83-120, S.M. Somani and J.A.J. Romano, eds. Washington, DC: CRC Press.
152. Southwick, M.S., M. Vythilingam and D.S. Charney. 2005. The psychobiology of depression and resilience to stress: implications for prevention and treatment. Annu Rev Clin Psychol 1: 255-91.
153. Spies, E.M. 1986. Chemical Warfare. Chicago, IL: University of Illinois Press.
154. Sterri, S.H., S. Lyngaas and F. Fonnum. 1980. Toxicity of soman after repetitive injection of sublethal doses in rat. Acta Pharmacol Toxicol (Copenh) 46(1): 1-7.
155. Stokes, J.W. and L.E. Banderet. 1997. Psychological aspects of chemical defense and warfare. Mil Psychol 9(4): 395-405.
156. Strange, R.E. 1968. Combat fatigue versus pseudo-combat fatigue in Vietnam. Mil Med 133(10): 823-6.
157. Strous, R.D., R. Stryjer, N. Keret, M. Bergin, and M. Kotler. 2003. Reactions of Psychiatric and medical inpatients to terror and security instability in Israel. J Nerv Ment Dis 191(2): 126-129.
158. Susser, E.S., D.B. Hunan and B. Aaron. 2002. Combating the terror of terrorism. Sci Am August: 70-77.
159. Thomson, S.A., R.J. Mioduszewski, S.A. Reutter, et al. 2005. Low Level Chemical Warfare Agent Toxicology Research Program FY04 Report and Analysis. Human Effectiveness Directorate, APG, MD AFRL/HE AFRL-HE-WP-TR-2005-0054.
160. Thomson, S.A., R.J. Mioduszewski, S.A. Reutter, et al. 2006. In Low Level Chemical Warfare Agent Toxicology Research Program FY05 Report and Analysis. Human Effectiveness Directorate, APG, MD AFRL/HE AFRL-HE-WP-TR-2006-0073.
161. Tronel, S. and C.M. Alberini. 2007. Persistent disruption of a traumatic memory by postretrieval inactivation of glucocorticoid receptors in the amygdala. Biol Psychiatry, 62(1): 33-39.
162. Ursano, R.J., H.C. Holloway, D.R. Jones, A.R. Rodriguez and G.L. Belenky. 1989. Psychiatric care in the military community: family and military stressors. Hosp Community Psychiatry 40(12): 1284-9.
163. U.S. Army Center for Health Promotion and Preventive Medicine. 2007. Chlorine Improvised Explosive Devices and Preventive Medicine Actions. http://usachppm.apgea.army.mil/documents/FACT/36-015-0407_Chlorine_IEDs.pdf.
164. Vaiva, G., V. Boss, F. Ducrocq, et al. 2006. Relationship between post trauma GABA plasma levels and PTSD at 1-year follow-up. Am J Psychiatry 163(8): 1446-8.
165. Vyner, H.M. 1988a. The psychological dimensions of health care for patients exposed to radiation and the other invisible environmental contaminants. Soc Sci Med 27(10): 1097-103.
166. Vyner, H.M. 1988b. Invisible Trauma: Psychosocial Effects of Invisible Environmental Contaminants. Lexington, MA: D.C. Heath Publishing Co.
167. Wexler, I.D., D. Branski and E. Kerem. 2006. War and children. JAMA 296(5): 579-81.
168. Willems, J.L. 1989. Clinical management of mustard gas casualties. Annales Medicinae Miliataris Belgicae 35: 1-61.
169. Wolthuis, O.L., R.A. Vanwersch and H.P. Van Helden. 1986. Residual behavioral incapacitation after therapy of soman intoxication: the effect of a soman simulator. Neurobehav Toxicol Teratol 8(2): 127-30.
170. Yanagisawa, N., H. Morita and T. Nakajima. 2006. Sarin experiences in Japan: acute toxicity and long-term effects. J Neurol Sci 249(1): 76-85.
171. Yehuda, R. 2006. Advances in understanding neuroendocrine alterations in PTSD and their therapeutic implications. Ann N Y Acad Sci 1071: 137-66.
172. Yehuda, R., E.L. Giller, S.M. Southwick, M.T. Lowy and J.W. Mason. 1991. Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry 30(10): 1031-48.
173. Yehuda, R., A.C. McFarlane and A.Y. Shalev. 1998a. Predicting the development of posttraumatic stress disorder from the acute response to a traumatic event. Biol Psychiatry 44(12): 1305-13.
174. Yehuda, R., L.J. Siever, M.H. Teicher, et al. 1998b. Plasma norepinephrine and 3-methoxy-4-hydroxyphenylglycol concentrations and severity of depression in combat posttraumatic stress disorder and major depressive disorder. Biol Psychiatry 44(1): 56-63.
175. Yehuda, R., J.A. Golier, R.K. Yang and L. Tischler. 2004. Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biol Psychiatry 55(11): 1110-6.
176. Yehuda, R., J.D. Flory, S. Southwick and D.S. Charney. 2006. Developing an agenda for translational studies of resilience and vulnerability following trauma exposure. Ann N Y Acad Sci 1071: 379-96.
177. Yokoyama, K., S. Araki, K. Murata, et al. 1998. Chronic neurobehavioral and central and autonomic nervous system effects of Tokyo subway sarin poisoning. J Physiol Paris 92(3-4): 317-23.